Cutaneous Manifestations, Clinical Trials, Safety Efficacy and Safety of Lenabasum in the Phase 3 DeterMine Trial in Dermatomyositis Werth, V., White, B., Concha, J., Dan, J., Dgetluck, N., Hally, K., Constantine, S., Aggarwal, R., Fiorentino, D., Lundberg, I., Oddis, C. WILEY. 2022: 323-325

View details for Web of Science ID 000877386500173